Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112627783 | 11262778 | 3 | F | 201003 | 20160704 | 20150710 | 20160711 | EXP | CA-PFIZER INC-2011257087 | PFIZER | 16.00 | YR | F | Y | 0.00000 | 20160711 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112627783 | 11262778 | 1 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 25 MG, 2X/WEEK | 0 | 25 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | BIW | ||||||
| 112627783 | 11262778 | 2 | SS | ENBREL | ETANERCEPT | 1 | UNK | 0 | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | ||||||||||
| 112627783 | 11262778 | 3 | PS | ARTHROTEC | DICLOFENAC SODIUMMISOPROSTOL | 1 | Oral | 75 MG, UNK | 20607 | 75 | MG | TABLET | |||||||
| 112627783 | 11262778 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 112627783 | 11262778 | 5 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | 0 | ||||||||||
| 112627783 | 11262778 | 6 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Unknown | UNK | 0 | ||||||||||
| 112627783 | 11262778 | 7 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 112627783 | 11262778 | 8 | SS | HUMIRA | ADALIMUMAB | 1 | 40 MG, EVERY 2 WEEKS | 0 | 40 | MG | |||||||||
| 112627783 | 11262778 | 9 | C | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | 20 MG, QWK | 0 | 20 | MG | /wk | |||||||
| 112627783 | 11262778 | 10 | C | METHOTREXATE. | METHOTREXATE | 1 | Oral | 25 MG, UNK | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112627783 | 11262778 | 1 | Juvenile idiopathic arthritis |
| 112627783 | 11262778 | 2 | Rheumatoid arthritis |
| 112627783 | 11262778 | 4 | Rheumatoid arthritis |
| 112627783 | 11262778 | 5 | Rheumatoid arthritis |
| 112627783 | 11262778 | 6 | Rheumatoid arthritis |
| 112627783 | 11262778 | 7 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112627783 | 11262778 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112627783 | 11262778 | Condition aggravated | |
| 112627783 | 11262778 | Drug ineffective | |
| 112627783 | 11262778 | Joint stiffness | |
| 112627783 | 11262778 | Juvenile idiopathic arthritis | |
| 112627783 | 11262778 | Rheumatoid arthritis | |
| 112627783 | 11262778 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112627783 | 11262778 | 1 | 20090903 | 201106 | 0 | |
| 112627783 | 11262778 | 8 | 201106 | 201109 | 0 | |
| 112627783 | 11262778 | 9 | 2009 | 201503 | 0 | |
| 112627783 | 11262778 | 10 | 201503 | 0 |